Professional Documents
Culture Documents
Biochemistry Lecture Enzymes
Biochemistry Lecture Enzymes
6. Ligase
➢ an enzyme that catalyzes the bonding
together of two molecules into one with the
participation of ATP.
Subtypes:
a. Carboxylases - use CO2 as a substrate
b. Synthetases - link two molecules via an ATP
dependent reaction
Enzyme Structure
➢ can be divided into two general structural
classes:
1. simple enzyme - an enzyme with only one
protein.
2. conjugated enzyme - an enzyme with a non- B. Lock and Key Hypothesis
protein part in addition to a protein part.
➢ This is the most accepted of the theories of
enzyme action.
➢ This theory states that the substrate fits
exactly into the active site of the enzyme to
form an enzyme-substrate complex.
➢ This model also describes why enzymes are
so specific in their action because they are
specific to the substrate molecules.
pH
➢ Enzymes are very sensitive to changes in the
pH and work in a very small window of
permissible pH levels.
➢ Below or above the optimum pH level, there
is a risk of the enzymes disintegrating and
thereby the reaction slows down.
HOW ARE ENZYMES REGULATED? E. Isoenzyme
A. Feedback Control ➢ enzyme that performs the same function but
have different combinations of subunits and
➢ an enzyme regulation process in which the
thus different quaternary structures
formation of a product inhibits an earlier
➢ lactate dehydrogenase catalyzes the
reaction in the sequence.
oxidation of lactate to pyruvate and vice
➢ the reaction product of one enzyme may
versa is an example.
control the activity of another.
Enzyme Inhibition
B. Proenzymes/ Zymogens
➢ an enzyme inhibitor is a substance that slows
➢ the inactive form of enzymes
or stops the normal catalytic function of an
➢ trypsin is manufactured in the pancreas as
enzyme by binding to it.
the inactive molecule trypsinogen (a
zymogen). When a fragment containing six Reversible Competetive Inhibition
amino acid residues is removed from the N-
➢ a competitive enzyme inhibitor is a molecule
Terminal end, the molecules become a fully
that resembles an enzyme substrate in shape
active trypsin molecule.
and charge distribution that it can compete
C. Allosteric Enzymes with the substrate for occupancy of the
enzyme’s active site.
➢ all allosteric enzymes have quaternary
structures; they are composed of two or Reversible Noncompetitive Inhibition
more protein subunits
➢ a non competitive inhibitor is an enzyme
➢ all allosteric enzymes have two kinds of
that decreases enzyme activity by binding to
building sites; those for substrate and those
a site on an enzyme other than the active site
for regulators
➢ substrate can still occupy the active site , but
➢ active and regulatory binding sites are
the presence of the inhibitor causes a change
distinct from each other in both location and
in the structure of the enzyme that catalytic
shape.
groups at the active site from properly
➢ binding of molecule at the regulatory site
effecting their catalytic action
causes change in the overall three
➢ heavy metal ions of Pb, Ag and Hg are
dimensional structure of the enzyme ,
examples of noncompetitive inhibitors.
including structural changes at the active site
❖ regulators are substances that bind at the Irreversible Inhibition
regulatory sites of an allosteric enzymes
➢ irreversible enzyme inhibitor is a molecule
D. Protein Modification that inactivates enzymes by forming a
strong covalent bond to an amino acid side
➢ a process in which enzyme activity is
chain group at the enzyme’s active site.
altered covalently modifying the structure
of the enzyme through attachment of a
chemical group to or removal of a chemical
group from a particular amino acid within
the enzyme’s structure
➢ an activation or inhibition of enzymes by
phosphorylation is the best-known example.
Medical Uses of Enzymes
❖ Sulfa Drugs
➢ the first antibiotics in the medical field
➢ sulfanilamide inhibits bacterial growth
that is structurally similar to PABA
(p-aminobenzoic acid)
➢ sulphanilamide acts as a competitive
inhibitor to enzymes in the biosynthetic
pathway for converting PABA to folic acid
❖ Penicillins
➢ inhibit transpeptidase, an enzyme that
catalyzes the formation of peptide cross-
link between polysaccharide strands in
bacterial cell walls.
➢ highly specific in binding to the active site
of transpeptidase
Ramos, Annyzha Mhaize A.
➢ acts as a very selective competitive
inhibitor BSN 1-B